GeoVax Labs, Inc. (GOVX) Insider Trading Disclosures
GeoVax Labs, Inc. (GOVX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GOVX
CIK: 832489
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Wipfli LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerRyan Barrow
Audit LocationAtlanta, Georgia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-09-23 | — | EFFECT Filing | 9999999995-26-003048 | View SEC Doc Filr Page |
| S-1 | 2026-09-17 | — | FORM S-1 | 0001437749-26-030676 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-10 | 2026-10-27 | FORM DEF 14A | 0001437749-26-030089 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | FORM 8-K | 0001437749-26-030085 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-31 | 2026-10-27 | FORM PRE 14A | 0001437749-26-029328 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-27 | FORM 8-K | 0001437749-26-029184 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-25 | FORM 8-K | 0001437749-26-029181 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003585 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001493152-26-037664 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-088830 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-10 | — | SCHEDULE 13G/A Filing | 0001595888-26-000089 | View SEC Doc Filr Page |
| 10-Q | 2026-07-27 | 2026-06-30 | FORM 10-Q | 0001437749-26-024523 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | FORM 8-K | 0001437749-26-024522 | View SEC Doc Filr Page |
| 8-K | 2026-07-10 | 2026-07-07 | FORM 8-K | 0001437749-26-023320 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021323 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021322 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021321 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021320 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021319 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021317 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021316 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021315 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021314 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021312 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | FORM 4 | 0001437749-26-021311 | View SEC Doc Filr Page |